Trials / Completed
CompletedNCT01767298
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, Four-Period Crossover Study in Healthy Egyptian Male Volunteers (PART II)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Damanhour University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to compare the rate and extent of absorption of valsartan and hydrochlorothiazide. To maximize the possibility of finding drug-drug interactions, the dose of valsartan and hydrochlorothiazide was doubled (320 mg of VAL and 25 mg of HCT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan/Hydrochlorothiazide | Co-administration or fixed dose combination |
| DRUG | Valsartan | Valsartan alone |
| DRUG | Hydrochlorothiazide | Hydrochlorothiazide alone |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2013-01-14
- Last updated
- 2013-01-14
Source: ClinicalTrials.gov record NCT01767298. Inclusion in this directory is not an endorsement.